Table 3 Characteristics of cases and matched controls within six months before the MI/index date
Cases n = 105 | Controls n = 105 | P value | |
|---|---|---|---|
CRP, mg/L, mean (SD) | 17.6 (25.0) | 10.4 (14.6) | 0.011 |
ESR, mm/h, mean (SD) | 36.1 (26.5) | 22.6 (16.2) | <0.001 |
DAS28, mean (SD) | 4.3 (1.4) | 4.0 (1.5) | 0.22 |
Tender joint count, mean (SD) | 4.2 (5.0) | 4.4 (5.6) | 0.71 |
Swollen joint count, mean (SD) | 3.8 (5.0) | 4.6 (5.4) | 0.17 |
NRS patient global health 0–10, mean (SD) | 5.1 (2.2) | 4.9 (2.0) | 0.41 |
FFbH, mean (SD) | 58.7 (27.1) | 61.0 (24.2) | 0.32 |
TNFi | 50 (47.6 %) | 55 (52.4 %) | 0.41 |
Other bDMARDs | 21 (20.0 %) | 23 (21.9 %) | 0.66 |
csDMARDs only | 33 (31.4 %) | 23 (21.9 %) | 0.11 |
Glucocorticoids, <5 mg/day | 44 (41.9 %) | 62 (59.6 %) | |
Glucocorticoids, 5–10 mg/day | 45 (42.9 %) | 34 (32.7 %) | 0.008 |
Glucocorticoids, ≥10 mg/day | 16 (15.2 %) | 8 (7.7 %) | |
Non-selective NSAIDs | 60 (57.1 %) | 62 (59.0 %) | 0.77 |
COX-2 inhibitors | 28 (26.7 %) | 36 (34.3 %) | 0.19 |
Any NSAID | 72 (68.6 %) | 78 (74.3 %) | 0.33 |